Clinical Research Directory
Browse clinical research sites, groups, and studies.
Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
Sponsor: University of Florida
Summary
Some research suggests that administration of oxytocin with oxycodone may reduce its abuse liability and improve its ability to reduce pain. In a 6-session laboratory study, the investigators will be evaluating the effects of oxycodone and oxytocin (combined and separately, across sessions) on experimentally-induced pain, subjective effects, decision-making, and activation of different neural substrates.
Key Details
Gender
All
Age Range
21 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2021-09-02
Completion Date
2026-12-31
Last Updated
2026-01-14
Healthy Volunteers
Yes
Conditions
Interventions
OxyCODONE 5 mg Oral Tablet
Oral oxycodone 5 mg orally
Oxytocin nasal spray
Intranasal oxytocin administration (48 IU)
Placebo Oxycodone
Oxycodone 0 mg orally
Placebo oxytocin
Intranasal placebo administration
OxyCODONE 2.5 mg Oral Tablet
Oral oxycodone 2.5 mg orally
Locations (1)
University of Florida
Gainesville, Florida, United States